| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Bluestone Jeffrey serves as a Director at GILD. Across recent SEC filings that breaks down to 0 buys and 3 sells. Those positions are worth an estimated $1.9M at current prices.
Historically, Bluestone Jeffrey's trades have earned a below-average insider score of 23/100 across 3 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -27.8%.
The biggest single holding is GILD (~$1.9M) as Director. The recent filings there lean toward selling, a net 16,788 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 28, 2025 | GILD Gilead Sciences, Inc. | Director | Sale+OE | 5,000 | $125.08 | $625,400.00 | -35.9% | +14.2% | - | |
| Jul 14, 2025 | GILD Gilead Sciences, Inc. | Director | Sale+OE | 5,000 | $109.74 | $548,700.00 | -35.9% | +5.5% | +16.0% | |
| Nov 26, 2024 | GILD Gilead Sciences, Inc. | Director | Sale+OE | 6,788 | $91.39 | $620,356.00 | -43.2% | +21.5% | +39.6% |